Natalizumab

CAS No. 189261-10-7

Natalizumab( —— )

Catalog No. M23864 CAS No. 189261-10-7

Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 218 In Stock
5MG 392 In Stock
10MG 629 In Stock
25MG 938 In Stock
50MG 1237 In Stock
100MG 1665 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Natalizumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.
  • Description
    Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    α4β1 integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    189261-10-7
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hutchinson M. Natalizumab: A new treatment for relapsing remitting multiple sclerosis. Ther Clin Risk Manag. 2007 Jun;3(2):259-68.
molnova catalog
related products
  • RGDS peptide

    RGDS peptide (Arg-Gly-Asp-Ser) is a integrin binding sequence that inhibits integrin receptor function, a tetrapeptide analogue of the cell attachment site of fibronectin.

  • Lifitegrast sodium

    Lifitegrast sodium (SAR-1118-023 sodium) is a small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), which reduces inflammation of the ocular surface, and may be used in the study of dry eye.

  • α2β1 integrin-IN-15

    α2β1 integrin-IN-15 highly potent, selective, allosteric small-molecule inhibitor of integrin α2β1 with IC50 of 12 nM.